Dr Kim Sweeny specialises in the strategic analysis, assessment and development of innovation. He has participated in a wide range of Centre projects in pharmaceuticals and healthcare, biotechnology, and nanotechnology.
He is engaged in long-term research on the pharmaceuticals, healthcare and the biotechnology industry in Australia and internationally, particularly in terms of the impact of regulatory and other influences on pharmaceutical pricing and demand.
Bertram, M.Y., Sweeny, K., Lauer, J.A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S.R., Dixit, L.P., George, K. and Deane, S. (2018), ‘Investing in non-communicable diseases: An estimation of the return on investment for prevention and treatment services’, Lancet, 4 April 2018, DOI: https://doi.org/10.1016/S0140-6736(18)30665-2
Patton, G.C., Olsson, C.A., Skirbekk, V., Saffery, R., Wlodek, M.E., Azzopardi, P.S., Stonawski, M., Rasmussen, B., Spry, E., Francis, K., Bhutta, Z.A., Kassebaum, N.J., Mokdad, A.H., Murray, C.J.L., Prentice, A.M., Reavley, N., Sheehan, P., Sweeny, K., Viner, R.M., Sawyer, S.M. (2018), ‘Adolescence and the next generation’, Nature, vol. 554, pp. 458-467, https://www.nature.com/articles/nature25759
Sheehan, P., Sweeny, K., Rasmussen, R., Wils, A., Friedman, H.S., Mahon, J., Patton, G.C., Sawyer, S.M., Howard, E., Symons, J., Stenberg, K., Chalasani, S., Maharaj, N., Reavley, N., Shi, H., Fridman, M., Welsh, A., Nsofor, E. and Laski, L. (2017) 'Building the foundations for sustainable development: A case for global investment in the capabilities of adolescents', The Lancet, online 19 April 2017, DOI: http://dx.doi.org/10.1016/S0140-6736(17)30872-3
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P. and Saxena, S. (2016) 'Scaling-up treatment of depression and anxiety: A global return on investment analysis', Lancet Psychiatry, vol. 3, no. 5, pp. 415-424, http://dx.doi.org/10.1016/S2215-0366(16)30024-4
Ten Hoppe-Bender, P., Stenberg, K. and Sweeny, K. (2016), ‘Reductions in stillbirths: More than a triple return on investment’, The Lancet, published online January 18, 2016, S0140-6736(15)01277, http://dx.doi.org/10.1016/
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A.M., Temmerman, M., Mason, E., Friedman, H.S., Bhutta, Z.A., Lawn, J.E., Sweeny, K., Tulloch, J., Hansen, P., Chopra, M., Gupta, A., Vogel, J.P., Ostergren, M., Rasmussen, B., Levin, C., Boyle, C., Kuruvilla, S., Koblinsky, M., Walker, N., de Francisco, A., Novcic, N., Presern, C., Jamison, D. and Bustreo, F. on behalf of the Study Group for the Global Investment Framework for Women’s Children’s Health (2014), ‘Advancing social and economic development by investing in women's and children's health: A new global investment framework’, The Lancet, 19 November, doi:10.1016/S0140-6736(13)62231-X.
Sweeny, K. (2009), ‘The impact of copayments and safety nets on PBS expenditure’, Australian Health Review, 33(2) 215-230.
Areas of expertise
- assessment and development of new technology and innovation
- strategic analysis